Sodium 4-hydroxybenzenesulfonate dihydrate, 95%, 100g

2-(2-Chloro-acetylamino)-4-(5-methyl-furan-2-yl)-thiophene-3-carboxylic acid ethyl ester, 95.0%, 250mg

[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-beta-homoleucine>96.0%(T)(HPLC)1g

Cbz-L-tert-Leucine, 95.0%, 500g

(2e)-3-(2-Bromopyridin-4-yl)prop-2-enoic acid, 95+%, 250mg

Ethyl 2-(3-bromophenoxy)acetate, 98.0%, 100g

Methyl 5-bromo-1H-indole-2-carboxylate, 95.0%, 5g

Ethyl 1-(N-hydroxycarbamimidoylmethyl)piperidine-4-carboxylate, 95.0%, 1g

Linsitinib, 250mg

(3-FLUORO-4-(METHOXYMETHYL)PHENYL)BORONIC ACID, 95.0%, 250mg

[4-(3,4-dimethylphenyl)piperazin-1-yl](3-methylphenyl)acetic acid, 250mg

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(2-tert-Butylphenyl)boronic acid, 97%, 100mg